Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Real-World Outcome of Psoriasis Patients in Korea on Adalimumab

The objective of this non-interventional, observational study is to assess the effect of adalimumab on health-related quality of life in participants with Psoriasis in Korea.

Inclusion Criteria:

• Participant has a diagnosis of Psoriasis by investigator.
• Participant (local definition according to adalimumab label) who is in compliance with eligibility for adalimumab based on the local label.
• Participant must be able and willing to provide written informed consent and comply with the requirements of this study protocol.

Exclusion Criteria:

• Participants who are pregnant or breast feeding at enrolment or wish to become pregnant in the next 24 weeks.
• Participation in any Psoriasis-related clinical trial at the time of enrolment, at baseline or at any point during the study period.
• Participants, who in the investigator's view, may not be able to accurately report their questionnaires